Leukocytoclastic vasculitis after COVID-19 vaccination
Citation
Altun, E. ve Kuzucular, E. (2022). Leukocytoclastic vasculitis after COVID-19 vaccination. Dermatologic Therapy, 35(3). https://dx.doi.org/10.1111/dth.15279Abstract
Leukocytoclastic vasculitis (LCV) is the vasculitis of small vessels. In this report, we describe a 38-year-old male patient who presented to our outpatient clinic with a 1-week history of rash on his lower extremities that had started 4 days after receiving the Pfizer-BioNTech SARS-CoV-2 vaccine. A diagnosis of LCV was made based on clinical and histopathological findings. The patient was treated with antihistamines and prednisolone, after which improvement was observed in the lesions. With this paper, we aim to raise awareness concerning the possibility of LCV development after COVID-19 vaccination.
WoS Q Kategorisi
Q2xmlui.dri2xhtml.METS-1.0.item-scopusquality
Q2Source
Dermatologic TherapyVolume
35Issue
3Collections
- Makale Koleksiyonu [3672]
- PubMed İndeksli Yayınlar Koleksiyonu [4080]
- Scopus İndeksli Yayınlar Koleksiyonu [6346]
- WoS İndeksli Yayınlar Koleksiyonu [6465]